Our strong R&D pipeline utilises its expertise in plasma fractionation, recombinant technology, and cell and gene therapy to develop and deliver innovative medicines that address unmet medical needs or enhance current treatments in five Therapeutic Areas - Immunology, Haematology, Cardiovascular and Metabolic, Respiratory and Transplant.What kind of business does CSL Behring have?
A global leader in treating bleeding disorders, CSL Behring has been delivering innovations for the hemophilia patient community for more than 30 years. The company reported more than $1 billion in sales of hemophilia-related medicines in 2020. uniQure Forward-Looking Statements This press release contains forward-looking statements.How to contact CSL customer service in Hong Kong?
If you are in any way suspicious about email claiming to be from csl, please forward it to [email protected] 。 Please call our service hotline on 2512 3123 if you have any inquiries.Who is the Managing Director of CSL Limited?
In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited